TrialEye (London, England)2022

Effectiveness and safety of ranibizumab in patients with central retinal vein occlusion: results from the real-world, global, LUMINOUS study.

Andrew Lotery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.